Beta
38120

Etodolac Softgels: Feasibility Assessment and Considerations for Lipid-Based Formulations of a highly hydrophobic drug

Article

Last updated: 22 Jan 2023

Subjects

-

Tags

-

Abstract

Oral lipid-based formulations provide a significant opportunity to address the poor and variable gastrointestinal absorption associated with poorly water soluble drugs. It is useful to discuss how a formulation can strategize various options creatively to overcome some of the challenges posed by the softgel dosage form development of a highly hydrophobic drug with large dose. Etodolac (ETO) was formulated in different lipid vehicle according to Lipid Formulation Classification System (LFCS) to optimize the appropriate fill composition and was subjected to different tests for characterization. Water migration studies, rupture test and mechanical properties of softgels were also performed to investigate the effect of the formulation materials on the integrity, physical stability of the prepared capsules and on the dissolution characteristics of drug. Selected formulations were assessed for in vitro dissolution profile and rupture test for softgel before and after accelerated and shelf stability for 3 months. Results revealed a correlation between the composition of the softgel core fill liquid and drug dissolution parameters. Application of hydrophilic surfactants showed a remarkable enhancement in the dissolution rate of drug. The extent of migration of a solute between a fill and a shell depends on the hydrophilicity of the solute, composition of the shell formulation. Antioxidants should be added to formulations containing hydrophilic surfactants which composed of polyoxyethylene moiety. Nominated formula containing polyethylene glycol/poloxamar 407 showed a good and stable dissolution results after accelerated and shelf stability in addition to better mechanical results.

DOI

10.21608/zjps.2017.38120

Keywords

Dissolution, Etodolac, Lipid based formulations, stability, Water migration

Authors

First Name

Ahmed

Last Name

N. Allam

MiddleName

-

Affiliation

1Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt

Email

ph.a.allam@gmail.com

City

-

Orcid

-

First Name

Ibrahim

Last Name

A. Komeil

MiddleName

-

Affiliation

2R&D pharmacist at Medizen Pharmaceutical Industries, Alexandria, Egypt

Email

-

City

-

Orcid

-

First Name

Ossama

Last Name

Abdallah

MiddleName

-

Affiliation

Department of Pharmaceutics, Faculty of Pharmacy, Alexandria University, Egypt

Email

-

City

-

Orcid

-

Volume

26

Article Issue

1

Related Issue

6151

Issue Date

2017-06-01

Receive Date

2019-07-01

Publish Date

2017-06-01

Page Start

1

Page End

12

Print ISSN

1110-5089

Online ISSN

2356-9786

Link

https://zjps.journals.ekb.eg/article_38120.html

Detail API

https://zjps.journals.ekb.eg/service?article_code=38120

Order

1

Type

Original Article

Type Code

862

Publication Type

Journal

Publication Title

Zagazig Journal of Pharmaceutical Sciences

Publication Link

https://zjps.journals.ekb.eg/

MainTitle

-

Details

Type

Article

Created At

22 Jan 2023